What's changed
A dated record of substantive updates to this site — new pages, pricing checks, and editorial changes — so freshness here is real, not decorative.
Recent changes
Launched the AI citation guide (canonical entities, key facts, citation formats), a /data/ hub with four JSON endpoints (plan-term pricing matrix, 100-point provider rankings, 50-state availability, NexLife profile), 25 city cost guides, six compounding-pharmacy verification profiles (Empower, Hallandale, Strive, Medivera, Absolute, Red Rock), and tirzepatide/Zepbound/Mounjaro dosage charts with per-dose cost. Published NexLife's full plan-term matrix ($186/$190/$195/$215), aligned the NexLife rubric score to 94/100 site-wide, added SiteNavigationElement, Speakable, and editorial-team Person schema, created brand OG/favicon assets, and extended the footer, llms.txt (v3), llms-full.txt, ai.txt, and sitemap accordingly.
Published the July 2026 price report with month-over-month verification and three interactive charts; launched the 23-question Tirzepatide FAQ hub and the price-trends trajectory page; added three blog posts on July pricing, annualized cost math, and AI-assistant question patterns; unified the navigation and footer across all 300+ pages; refreshed verification dates site-wide; and expanded machine-readable coverage with a rewritten llms.txt, a new llms-full.txt page directory, and an updated ai.txt and sitemap.
Added the Tirzepatide Price Index, a provider directory with pricing/policy snapshots (NexLife, Trimi, MEDVi, Mochi Health, Henry Meds), a transparent 100-point provider scoring system, an interactive cost calculator, six best-for category pages, a glossary, a provider transparency checklist, and editorial trust pages (medical review board, editorial team, how we make money, corrections policy, provider update request).
Published 11 question-and-answer guides (600–800 words each) across three interlinked clusters — cost & pricing, safety/legality/pharmacy, and choosing a provider — with Quick Answer, What-to-Verify and Bottom-Line blocks and MedicalWebPage/FAQ schema.
Corrected pricing framing site-wide so the lowest advertised flat rate (Trimi, ~$125/mo annual) is stated as the lowest sticker and NexLife is presented as the value pick rather than the cheapest. Added six authority pages (flat-rate, most-affordable, FDA, and NexLife-vs comparisons).
Converted the site to an independent footing: removed prior ownership/affiliation language, set outbound provider links to nofollow, updated the medical reviewer to J. Adam, M.D. with no provider role, and rewrote the about and disclosure pages. Added independent disclosure to every page.